help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 73, No. 3 489-494
doi:10.1210/jcem-73-3-489
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HANSSENS, M.
Right arrow Articles by VAN ASSCHE, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HANSSENS, M.
Right arrow Articles by VAN ASSCHE, F. A.

Measurement of Individual Plasma Angiotensins in Normal Pregnancy and Pregnancy-Induced Hypertension*

MYRIAM HANSSENS, MARC J. N. C. KEIRSE, BERNARD SPITZ and F. ANDRE VAN ASSCHE

Department of Obstetrics and Gynecology, University of Leuven U.Z. Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
The Department of Obstetrics, Gynecology, and Reproduction, Leiden University Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands

Address all correspondence and requests for reprints to: Dr. M. Hanssens, Department of Obstetrics and Gynecology, U.Z. Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.

Individual angiotensin peptides were measured by a high pressure liquid chromatography-RIA (HPLC-RIA) technique in the plasma of 20 nonpregnant women, 17 women with normal pregnancy, and 49 with pregnancy-induced hypertension. Immunoreactive angiotensin-II (ANG-II) consisted mainly of ANG-(l–8) octapeptide (>65%), variable proportions (15-25%) of ANG-(4–8) pentapeptide, and small to negligible proportions of ANG-(2–8) heptapeptide and ANG-(3–8) hexapeptide. Levels of ANG-(l–8) were significantly higher in women with normal pregnancy than in both nonpregnant women (P < 0.0006) and women with pregnancy-induced hypertension (P < 0.008); in the latter, levels were lower with increasing severity of disease. Levels of ANG-(4–8) were higher in women with normal pregnancy than in women with pregnancy-induced hypertension or nonpregnant women. When expressed as a proportion of ANG-(l–8) levels, however, ANG-(4–8) levels were not higher in normal pregnancy than in women with pregnancyinduced hypertension or nonpregnant women. It is concluded that the well known increase in ANG-II levels in normal pregnancy relates predominantly to the active ANG-(l–8) octapeptide and to a far lesser extent to the smaller ANG peptides. Similarly, lower ANG-II levels in pregnancy-induced hypertension relate predominantly to lower ANG-(1–8) levels.

* This work was supported by FWGO (Grant 3.0069.85), KULResearch Foundation (OT 85/54), and the Queen Elisabeth Foundation, Brussels.

Received October 5, 1990.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J. GREEN, S. ASSADY, F. NAKHOUL, T. BICK, P. JAKOBI, and Z. ABASSI
Differential Effects of Sera from Normotensive and Hypertensive Pregnant Women on Ca2+ Metabolism in Normal Vasular Smooth Muscle Cells
J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1188 - 1198.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society